1.Risk factors and sonographic findings associated with the type of placenta accreta spectrum disorders
Huijing ZHANG ; Ruochong DOU ; Li LIN ; Qianyun WANG ; Beier HUANG ; Xianlan ZHAO ; Dunjin CHEN ; Yiling DING ; Hongjuan DING ; Shihong CUI ; Weishe ZHANG ; Hong XIN ; Weirong GU ; Yali HU ; Guifeng DING ; Hongbo QI ; Ling FAN ; Yuyan MA ; Junli LU ; Yue YANG ; Li LIN ; Xiucui LUO ; Xiaohong ZHANG ; Shangrong FAN ; Huixia YANG
Chinese Journal of Obstetrics and Gynecology 2019;54(1):27-32
Objective To evaluate the risk factors and sonographic findings of pregnancies complicated by placenta increta or placenta percreta. Methods Totally, 2219 cases were retrospectively analyzed from 20 tertiary hospitals in China from January 2011 to December 2015. The data were collected based on the original case records. All cases were divided into two groups, the placenta increta (PI) group (79.1%, 1755/2219) and the placenta percreta (PP) group (20.9%, 464/2219), according to the degree of placental implantation. The risk factors and sonographic findings of placenta increta or percreta were analyzed by uni-factor and logistic regression statistic methods. Results The risk factors associated with the degree of placental implantation were age, gravida, previous abortion or miscarriage, previous cesarean sections, and placenta previa (all P<0.05), especially, previous cesarean sections (χ2=157.961) and placenta previa (χ2=91.759). Sonographic findings could be used to predict the degree of placental invasion especially the boundaries between placenta and uterine serosa, the boundary between placenta and myometrium, the disruption of the placental-uterine wall interface and loss of the normal retroplacental hypoechoic zone(all P<0.01). Conclusions Previous cesarean sections and placenta previa are the main independent risk factors associated with the degree of placenta implantation. Ultrasound could be used to make a prenatal suggestive diagnosis of placenta accreta spectrum disorders.
2.Color Doppler flow imaging for predicting the proteinuria following pyeloplasty for congenital ureteropelvic junction obstruction
Jin ZHANG ; Wei JIA ; Wen FU ; Guochang LIU ; Qianyun ZHANG ; Shibo ZHU ; Tianxin ZHAO ; Zhengtao ZHANG ; Zijie YE
Chinese Journal of Urology 2022;43(12):920-924
Objective:Objectives To investigate the predictive value of color Doppler flow imaging (CDFI) for the proteinuria following pyeloplasty for congenital ureteropelvic junction obstruction (UPJO) in children.Methods:We identified a series of 206 children with a mean age of (20.0±28.8) months (1-132 months), consisted of 171 males and 35 females, diagnosed with congenital UPJO accepted pyeloplasty from January 2014 to September 2018, the preoperative mean urinary Albumin/Creatinine Ratio (ACR) was (17.3±160.1) mg/mmol and the mean β2-microglobulin/Creatinine Ratio (β2-MG/Cr) was (135.6±383.8) μg/mmol, ultrasound showed a mean renal pelvis dilatation of (3.1±1.5) cm and a mean cortical thickness of (0.3±0.1) cm, and classified as grade Ⅰ-Ⅴ according to the blood flow distribution in renal by CDFI, these children were divided into three groups of increased, decreased and unchanged blood flow according to the postoperative CDFI within 1 week, the postoperative urinary protein and renal function indexes within 1 week and 2 years were retrospectively analysed among groups.Results:Within 1 week postoperatively, an increased, decreased and unchanged blood flow occurred in 113 (54.9%), 31(15.0%), 62(30.1%) children, respectively. Urinary ACR in above mentioned groups was (112.3±400.7), (16.1±29.3), (32.7±48.4) mg/mmol, β2-MG/Cr was (887.4±6061.0), (50.2±62.7), (51.9±57.8)μg/mmol, there were significant differences among groups ( P<0.01). Contralateral hydronephrosis occurred in 21(18.6%), 4(12.9%), 8(12.9%) children, urinary N-Acetyl-β-D-glucosaminidase (NAG) was (7.5±5.2), (7.0±5.4)、(5.7±4.5) U/L, these indexes showed no significant differences among groups. There was a positive correlation between the increased blood flow level and the decreased renal pelvis dilatation (Spearman’s correlation coefficient 0.2, P<0.01), ACR (Spearman’s correlation coefficient 0.4, P<0.01) and β2-MG/Cr (Spearman’s correlation coefficient 0.3, P<0.01). After a follow up of 2 years, 67 children were diagnosed with proteinuria in this series, 51 cases of them with an increased blood flow, which had significantly higher percentage than children with a decreased (4 cases, 12.9%) or unchanged blood flow (12 cases, 19.3%). Logistic multivariate analysis indicated that early postoperative (within 1 week) increased blood flow ( OR=1.9, 95% CI 1.5-2.6), contralateral hydronephrosis ( OR=2.2, 95% CI 1.1-4.8) and urinary NAG ( OR=1.1, 95% CI 1.0-1.1) were predictive of proteinuria, the increased blood flow was independent predictor of proteinuria (Ⅰ level increased: OR=1.9, 95% CI 1.5-2.6). Conclusions:The CDFI reveals good predictive value for the postoperative proteinuria, an early marked increased blood flow postoperatively indicated risk of proteinuria in the long term.
3.Small molecule inhibitors of RORγt for Th17 regulation in inflammatory and autoimmune diseases
Jiuping ZENG ; Mingxing LI ; Qianyun ZHAO ; Meijuan CHEN ; Long ZHAO ; Shulin WEI ; Huan YANG ; Yueshui ZHAO ; Anqi WANG ; Jing SHEN ; Fukuan DU ; Yu CHEN ; Shuai DENG ; Fang WANG ; Zhuo ZHANG ; Zhi LI ; Tiangang WANG ; Shengpeng WANG ; Zhangang XIAO ; Xu WU
Journal of Pharmaceutical Analysis 2023;13(6):545-562
As a ligand-dependent transcription factor,retinoid-associated orphan receptor γt(RORyt)that controls T helper(Th)17 cell differentiation and interleukin(IL)-17 expression plays a critical role in the pro-gression of several inflammatory and autoimmune conditions.An emerging novel approach to the therapy of these diseases thus involves controlling the transcriptional capacity of RORyt to decrease Th17 cell development and IL-17 production.Several RORyt inhibitors including both antagonists and inverse agonists have been discovered to regulate the transcriptional activity of RORyt by binding to orthosteric-or allosteric-binding sites in the ligand-binding domain.Some of small-molecule inhibitors have entered clinical evaluations.Therefore,in current review,the role of RORyt in Th17 regulation and Th17-related inflammatory and autoimmune diseases was highlighted.Notably,the recently developed RORyt inhibitors were summarized,with an emphasis on their optimization from lead compounds,ef-ficacy,toxicity,mechanisms of action,and clinical trials.The limitations of current development in this area were also discussed to facilitate future research.
4.Design and Feasibility Study of Tracheal Intubation Device Based on Magnetic Navigation Technology.
Rongfeng WANG ; Qianyun ZHANG ; Hongfan DING ; Haoyang ZHU ; Chang LIU ; Zheng GUAN ; Ge ZHAO ; Qiang WANG ; Yi LYU
Chinese Journal of Medical Instrumentation 2021;45(1):22-25
OBJECTIVE:
In the context of coronavirus disease 2019 (COVID-19) pandemic, the subject was designed to develop a new tracheal intubation device based on magnetic navigation technology to improve the success rate of tracheal intubation and reduce the risk of occupational exposure of medical staff.
METHODS:
The new tracheal intubation device was designed with the uniqueness of the magnetic field environment and magnetic steering of magnetic navigation technology. And preliminary magnetic navigation tracheal intubation experiments were performed on the tracheal intubation simulator.
RESULTS:
Magnetic navigation tracheal intubation can successfully implement tracheal intubation, and the time required is lower than that of traditional laryngoscopy.
CONCLUSIONS
The tracheal intubation based on magnetic navigation technology is feasible, with high efficiency and easy operation. That is expected to be widely used for tracheal intubation during treatment of patients outside the hospital in the future. At the same time, magnetic navigation endotracheal intubation technology will be the key technology for the development of endotracheal intubation robots.
COVID-19/therapy*
;
Equipment Design
;
Feasibility Studies
;
Humans
;
Intubation, Intratracheal
;
Magnetic Phenomena
;
SARS-CoV-2
;
Technology
5.Chinese herbal medicines for treating ulcerative colitis via regulating gut microbiota-intestinal immunity axis.
Yifei YANG ; Yi WANG ; Long ZHAO ; Fang WANG ; Mingxing LI ; Qin WANG ; Haoming LUO ; Qianyun ZHAO ; Jiuping ZENG ; Yueshui ZHAO ; Fukuan DU ; Yu CHEN ; Jing SHEN ; Shulin WEI ; Zhangang XIAO ; Xu WU
Chinese Herbal Medicines 2023;15(2):181-200
Ulcerative colitis (UC) is one of types of inflammatory bowel disease with high recurrence. Recent studies have highlighted that microbial dysbiosis as well as abnormal gut immunity are crucial factors that initiate a series of inflammatory responses in the UC. Modulating the gut microbiota-intestinal immunity loop has been suggested as one of key strategies for relieving UC. Many Chinese herbal medicines including some of single herb, herbal formulas and the derived constituents have been reported with protective effect against UC through modulating gut microbiome and intestinal immunity. Some clinical trials have shown promising results. This review thus focused on the current knowledge on using Chinese herbal medicines for treating UC from the mechanism aspects of regulating intestinal homeostasis involving microbiota and gut immunity. The existing clinical trials are also summarized.